Sweden cancer diagnostics product outlook (Revenue, USD million, 2021-2033)
- Instruments
- Pathology-based Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- PCR Instruments
- NGS Instruments
- Microarrays
- Other Pathology-based Instruments
- Imaging Instruments
- Other
- Consumables
- Antibodies
- Kits & reagents
- Probes
- Others
- Services
Sweden cancer diagnostics type outlook (Revenue, USD million, 2021-2033)
- IVD
- Diagnosis
- Early Detection
- Therapy Selection
- Monitoring
- LDT
- Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Ultrasound
- Others
Sweden cancer diagnostics ivd by technology outlook (Revenue, USD million, 2021-2033)
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-generation Sequencing (NGS)
- Microarrays
- Flow Cytometry
- Immunoassays
- Other IVD Testing Technologies
Sweden cancer diagnostics application outlook (Revenue, USD million, 2021-2033)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
Sweden cancer diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Laboratories
- Others
Sweden cancer diagnostics test type outlook (Revenue, USD million, 2021-2033)
- Biopsy
- Fine-needle Aspiration
- Core Biopsy
- Surgical Biopsy
- Skin Biopsy /Punch Biopsy
- Others
- Others
